Danirixin (GSK1325756)

Danirixin · GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Danirixin (GSK1325756), covering 2017-05-09 to 2017-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Danirixin (GSK1325756) Inhibition of CD11b Cell Surface Expression [Phase 1]